1826819-57-1

1826819-57-1 structure

Name: Azintuxizumab
Chemical Name: Azintuxizumab
CAS Number: 1826819-57-1
Molecular Formula:
Molecular Weight:
Catalog: Research Areas Cancer
Create Date: 2023-01-26 18:07:47
Modify Date: 2024-01-21 10:56:41
Azintuxizumab (ABBV-383; PR-1471272) is a SLAMF7 targeting antibody-drug conjugate (ADC). Azintuxizumab consists of a SLAMF7-targeted mAb and a monomethyl auristatin E (MMAE) via a cathepsin B-cleavable peptide linker. Azintuxizumab has the potential for the research of multiple myeloma[1].

Name	Azintuxizumab

Description	Azintuxizumab (ABBV-383; PR-1471272) is a SLAMF7 targeting antibody-drug conjugate (ADC). Azintuxizumab consists of a SLAMF7-targeted mAb and a monomethyl auristatin E (MMAE) via a cathepsin B-cleavable peptide linker. Azintuxizumab has the potential for the research of multiple myeloma[1].
Related Catalog	Research Areas >> Cancer
References	[1]. Romano A, et al. Mechanisms of Action of the New Antibodies in Use in Multiple Myeloma. Front Oncol. 2021 Jul 8;11:684561.

No Any Chemical & Physical Properties